SoftOx Solutions AS
SoftOx Solutions AS, together with its subsidiaries, operates as a clinical-stage pharmaceutical company that develops antimicrobials products for infection prevention and treatment in Norway. The company develops SoftOx Inhalation Solution, an inhalation solution that is phase II clinical trial for the treatment of ventilator associated pneumonia and other airway infections. It also developing p… Read more
SoftOx Solutions AS - Asset Resilience Ratio
SoftOx Solutions AS (SOFTX) has an Asset Resilience Ratio of 18.73% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2024)
This chart shows how SoftOx Solutions AS's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down SoftOx Solutions AS's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Nkr22.82 Million | 18.73% |
| Short-term Investments | Nkr0.00 | 0% |
| Total Liquid Assets | Nkr22.82 Million | 18.73% |
Asset Resilience Insights
- Good Liquidity Position: SoftOx Solutions AS maintains a healthy 18.73% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
SoftOx Solutions AS Industry Peers by Asset Resilience Ratio
Compare SoftOx Solutions AS's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
MedPacto Inc
KQ:235980 |
Biotechnology | 49.82% |
|
Shenzhen CAU Technology Co Ltd
SHE:000004 |
Biotechnology | 6.20% |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403 |
Biotechnology | 6.88% |
|
Nanhua Bio Medicine Co Ltd
SHE:000504 |
Biotechnology | 11.93% |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518 |
Biotechnology | 0.03% |
|
Chengzhi Shareholding Co Ltd
SHE:000990 |
Biotechnology | 6.73% |
|
Hualan Biological EngineeringInc
SHE:002007 |
Biotechnology | 14.68% |
|
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030 |
Biotechnology | 4.35% |
Annual Asset Resilience Ratio for SoftOx Solutions AS (2016–2024)
The table below shows the annual Asset Resilience Ratio data for SoftOx Solutions AS.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 8.68% | Nkr10.51 Million | Nkr121.14 Million | +0.81pp |
| 2023-12-31 | 7.87% | Nkr7.65 Million | Nkr97.24 Million | -1.00pp |
| 2022-12-31 | 8.87% | Nkr6.91 Million | Nkr77.83 Million | -44.29pp |
| 2021-12-31 | 53.17% | Nkr56.98 Million | Nkr107.18 Million | +13.31pp |
| 2020-12-31 | 39.86% | Nkr34.80 Million | Nkr87.31 Million | -32.54pp |
| 2019-12-31 | 72.40% | Nkr76.00 Million | Nkr104.96 Million | +67.12pp |
| 2018-12-31 | 5.29% | Nkr1.24 Million | Nkr23.39 Million | -49.80pp |
| 2017-12-31 | 55.09% | Nkr17.10 Million | Nkr31.04 Million | +51.68pp |
| 2016-12-31 | 3.41% | Nkr301.99K | Nkr8.86 Million | -- |